Literature DB >> 8780702

Phosphorylation of the proteasome activator PA28 is required for proteasome activation.

N Li1, K M Lerea, J D Etlinger.   

Abstract

PA28, also referred to as 11S regulator, is a potent activator of the peptidase activities of the proteasome (multicatalytic proteinase complex). Although the role(s) of PA28-20S proteasome complexes in cellular proteolytic processes remain to be defined, these particles have been implicated in antigen processing of major histocompatibility complex (MHC) class I molecules. Our results demonstrate that PA28 is phosphorylated as evidenced by 32P incorporation into a single PA28 species in rabbit reticulocytes. In reticulocytes as well as human erythrocytes, PA28 is normally found in a phosphorylated state as detected by phosphoserine antibody. In human erythrocytes, this antibody recognizes three polypeptides which are also detected by antibody to PA28 on Western blot analysis. Dephosphorylation with alkaline phosphatase treatment completely abolishes the ability of PA28 to activate hydrolysis of Suc-Leu-Leu-Val-Tyr by proteasomes. After exposure to phosphatase, the three polypeptides are no longer recognized by phosphoserine antibody, although binding to PA28 antibody is unaffected. These results suggest that phosphorylation may function in transduction of cytokine and growth factor signals that, in turn, modulate antigen presentation and other processes which involve PA28-20S proteasome complexes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8780702     DOI: 10.1006/bbrc.1996.1263

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  14 in total

Review 1.  Phosphorylation of proteasomes in mammalian cells.

Authors:  S Bose; G G Mason; A J Rivett
Journal:  Mol Biol Rep       Date:  1999-04       Impact factor: 2.316

2.  PA200, a nuclear proteasome activator involved in DNA repair.

Authors:  Vicença Ustrell; Laura Hoffman; Gregory Pratt; Martin Rechsteiner
Journal:  EMBO J       Date:  2002-07-01       Impact factor: 11.598

Review 3.  Post-translational modification of cardiac proteasomes: functional delineation enabled by proteomics.

Authors:  Sarah B Scruggs; Nobel C Zong; Ding Wang; Enrico Stefani; Peipei Ping
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-04-20       Impact factor: 4.733

4.  Keeping proteasomes under control--a role for phosphorylation in the nucleus.

Authors:  Zhe Sha; Andreas Peth; Alfred L Goldberg
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-07       Impact factor: 11.205

Review 5.  The utility of ETD mass spectrometry in proteomic analysis.

Authors:  Leann M Mikesh; Beatrix Ueberheide; An Chi; Joshua J Coon; John E P Syka; Jeffrey Shabanowitz; Donald F Hunt
Journal:  Biochim Biophys Acta       Date:  2006-10-30

Review 6.  Structural and functional properties of proteasome activator PA28.

Authors:  L Kuehn; B Dahlmann
Journal:  Mol Biol Rep       Date:  1997-03       Impact factor: 2.316

Review 7.  Proteasome Biology: Chemistry and Bioengineering Insights.

Authors:  Lucia Račková; Erika Csekes
Journal:  Polymers (Basel)       Date:  2020-12-04       Impact factor: 4.329

Review 8.  The proteasome activator 11 S REG (PA28) and class I antigen presentation.

Authors:  M Rechsteiner; C Realini; V Ustrell
Journal:  Biochem J       Date:  2000-01-01       Impact factor: 3.857

Review 9.  Regulation of cardiac proteasomes by ubiquitination, SUMOylation, and beyond.

Authors:  Ziyou Cui; Sarah B Scruggs; Jennifer E Gilda; Peipei Ping; Aldrin V Gomes
Journal:  J Mol Cell Cardiol       Date:  2013-10-17       Impact factor: 5.000

10.  MEKK3 interacts with the PA28 gamma regulatory subunit of the proteasome.

Authors:  Carsten Hagemann; Rajnikant Patel; Jonathan L Blank
Journal:  Biochem J       Date:  2003-07-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.